129 related articles for article (PubMed ID: 3205834)
1. Cancer-associated hemolytic uremic syndrome.
Hrozencik SP; Connaughton MJ
Oncol Nurs Forum; 1988; 15(6):755-9. PubMed ID: 3205834
[No Abstract] [Full Text] [Related]
2. [Hemolytic-uremic syndrome caused by mitomycin C].
de Insausti CL; Gutiérrez LE
Sangre (Barc); 1988 Aug; 33(4):319-20. PubMed ID: 3142062
[No Abstract] [Full Text] [Related]
3. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
Kikuchi H; Kanamaru R
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1927-9. PubMed ID: 1519930
[TBL] [Abstract][Full Text] [Related]
4. [Chemotherapy of adenocarcinoma of the stomach].
Zeitoun P; Lirzin P
Ann Gastroenterol Hepatol (Paris); 1984; 20(4):213-7. PubMed ID: 6442117
[No Abstract] [Full Text] [Related]
5. Combined nonsimultaneous radiation therapy and chemotherapy with 5-FU, doxorubicin, and mitomycin for residual localized gastric adenocarcinoma: a Southwest Oncology Group pilot study.
Haas CD; Mansfield CM; Leichman LP; Considine B; Bukowski RM
Cancer Treat Rep; 1983 May; 67(5):421-4. PubMed ID: 6687837
[No Abstract] [Full Text] [Related]
6. FAM (5-fluorouracil, doxorubicin, and mitomycin) plus triazinate (FAM-T) in gastric carcinoma: a combined phase II trial of the Mid-Atlantic Oncology Program and the Pan American Health Organization.
Ahlgren JD; Smith FP; Cazap E; Estevez RA; Marantz A; Woolley PV; Wilcosky T; Stein J; Schein PS
Cancer Treat Rep; 1987 Apr; 71(4):419-20. PubMed ID: 3548959
[No Abstract] [Full Text] [Related]
7. Gastric cancer: complete chemotherapy response in an elderly woman: current status of treatment.
Hagin GD; Jain A
Am J Gastroenterol; 1985 Nov; 80(11):835-7. PubMed ID: 3840327
[TBL] [Abstract][Full Text] [Related]
8. [Adjuvant chemotherapy in advanced stomach cancer].
Zehner J; Weber L; Fischer M; Gfirtner H; Breit A
Med Klin (Munich); 1986 Jun; 81(13):445-8. PubMed ID: 3785030
[No Abstract] [Full Text] [Related]
9. [Chemotherapy of gastrointestinal cancer in the advanced stage with a combination of 5-fluorouracil, adriamycin, mitomycin C (FAM). A non-controlled study].
Grieco A; Lasorella A; Astone A; Vagliviello L; Bartoloni C; Barone C
Clin Ter; 1984 Aug; 110(4):353-8. PubMed ID: 6237871
[No Abstract] [Full Text] [Related]
10. Carcinoma-associated hemolytic-uremic syndrome in a patient receiving 5-fluorouracil-adriamycin-mitomycin C combination chemotherapy.
Mergenthaler HG; Binsack T; Wilmanns W
Oncology; 1988; 45(1):11-4. PubMed ID: 3124028
[TBL] [Abstract][Full Text] [Related]
11. Chemotherapy of gastric cancer.
Schein PS
Acta Chir Scand Suppl; 1988; 541():13-5. PubMed ID: 2455406
[No Abstract] [Full Text] [Related]
12. O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.
Ahlgren J; Patel N; Simmens S; Akin E; Bishop C; Kirkel D; Siegel P; Schuck S; Guebre-Xabiher H; Siegel R
Oncology; 2014; 87(6):371-80. PubMed ID: 25227924
[TBL] [Abstract][Full Text] [Related]
13. Acute non-lymphocytic leukemia following FAM combination adjuvant chemotherapy for gastric and lung adenocarcinoma.
Bouillet T; Lepage E; Gisselbrecht C; Boiron M
Nouv Rev Fr Hematol (1978); 1990; 32(3):207-9. PubMed ID: 2120675
[TBL] [Abstract][Full Text] [Related]
14. [A gastric cancer patient who underwent curative resection by angiotension-induced hypertension cancer chemotherapy].
Hakuta Y; Kimura T; Ashizawa I; Sato S; Hara T; Nakazima K
Gan No Rinsho; 1984 Jan; 30(1):66-9. PubMed ID: 6422102
[TBL] [Abstract][Full Text] [Related]
15. [Microangiopathic hemolytic anemia associated with gastric cancer].
Kanou T; Nosou Y; Yoshinaka K; Yanagawa E; Niimoto M; Hattori T; Miura K; Kuramoto J
Gan No Rinsho; 1986 Aug; 32(9):1029-34. PubMed ID: 3091884
[TBL] [Abstract][Full Text] [Related]
16. Treatment of advanced gastric carcinoma with mitomycin and doxorubicin.
Dalley D; Erlichman C; Fine S
Cancer Treat Rep; 1986 Jul; 70(7):897-8. PubMed ID: 3719582
[TBL] [Abstract][Full Text] [Related]
17. [Chemotherapy-induced hemolytic uremic syndrome. A complication to mitomycin treatment of breast carcinoma].
Schjølseth SA; Hagen T; Ottestad L; Jakobsen E
Tidsskr Nor Laegeforen; 1995 Nov; 115(27):3371-3. PubMed ID: 7491579
[TBL] [Abstract][Full Text] [Related]
18. Phase I--II study of the combination of 5-FU, doxorubicin, mitomycin, and semustine (FAMMe) in the treatment of adenocarcinoma of the stomach, gastroesophageal junction, and pancreas.
Karlin DA; Stroehlein JR; Bennetts RW; Jones RD; Heifetz LJ; Mahal PS
Cancer Treat Rep; 1982 Aug; 66(8):1613-7. PubMed ID: 7105051
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of advanced stage gastric carcinoma: FAM versus chemotherapeutic regimens excluding adriamycin].
Repetto L; Campora E; Nobile MT; Rosso R
G Ital Chemioter; 1985; 32(1):57-8. PubMed ID: 3841661
[No Abstract] [Full Text] [Related]
20. [FAM as a palliative chemotherapy for gastric cancer with bone metastasis].
Yumoto Y; Okuda T; Shimizu S; Kawase K
Gan To Kagaku Ryoho; 1996 Jan; 23(1):107-10. PubMed ID: 8546459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
